A 70 year old man with a known history of Parkinson’s disease is to receive prophylaxis against Influenza A virus. He is given a drug that is useful against Parkinson’s disease as well for prophylaxis against influenza. The drug with which of the following mechanisms of action is most likely to have been given?

**Core Concept**
The question tests the understanding of a drug that has a dual role in managing Parkinson's disease and providing prophylaxis against Influenza A virus, highlighting the principle of **neuroprotection** and **antiviral** properties.

**Why the Correct Answer is Right**
The correct answer is related to the mechanism of action of a drug that can provide both neurological benefits and antiviral effects. Amantadine is a drug known for its use in Parkinson's disease treatment and also has been used for prophylaxis against Influenza A virus. It works by **inhibiting the influenza A virus M2 protein**, which is crucial for the virus's replication.

**Why Each Wrong Option is Incorrect**
**Option A:** This choice does not relate to a drug used for both Parkinson's disease and Influenza A prophylaxis.
**Option B:** Similarly, this option does not match the dual-action profile required.
**Option D:** This choice does not correspond with the known dual-action drugs for Parkinson's and Influenza A.

**Clinical Pearl / High-Yield Fact**
Amantadine is a notable drug for its dual use, offering a unique example of a medication that can provide benefits in both neurology and infectious diseases, particularly useful in elderly patients with multiple health concerns.

**Correct Answer:** D. Amantadine.

✓ Correct Answer: B. It prevents uncoating of the virus